The net benefit of thrombolysis in the management of intermediate risk pulmonary embolism: Systematic review and meta‐analysis

PE Alcedo, HA García‐Perdomo… - Ejhaem, 2020 - Wiley Online Library
Background Benefit of thrombolytic therapy in patients with massive pulmonary embolism
(PE) is evident. However, evidence supporting benefit in clinical outcomes of this approach …
被引用次数：6 相关文章

The net benefit of thrombolysis in the management of intermediate risk pulmonary embolism: Systematic review and meta-analysis

PE Alcedo, HA García-Perdomo… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Benefit of thrombolytic therapy in patients with massive pulmonary embolism
(PE) is evident. However, evidence supporting benefit in clinical outcomes of this approach …

The net benefit of thrombolysis in the management of intermediate risk pulmonary embolism: Systematic review and meta-analysis.

PE Alcedo, HA García-Perdomo, CM Rojas-Hernandez - Ejhaem, 2020 - europepmc.org
The net benefit of thrombolysis in the management of intermediate risk pulmonary embolism:
Systematic review and meta-analysis. - Abstract - Europe PMC Sign in | Create an account …
[HTML] nih.gov

[HTML][HTML] The net benefit of thrombolysis in the management of intermediate risk pulmonary embolism: Systematic review and meta‐analysis

PE Alcedo, HA García‐Perdomo… - EJHaem, 2020 - ncbi.nlm.nih.gov
The net benefit of thrombolysis in the management of intermediate risk pulmonary embolism:
Systematic review and meta‐analysis - PMC Back to Top Skip to main content NIH NLM Logo …